Gina Shaw

Montclair, Upper Montclair

Independent Medical and Health Writer at Freelance

Health writer, cancer survivor, mom of three, theater junkie, passionate traveler, super liberal nerd. She/her. All opinions solely mine.

Featured in: Favicon

webmd.com

huffingtonpost.co.uk Favicon

medscape.com Favicon

lww.com

health.com Favicon

healthcentral.com Favicon

nwitimes.com Favicon

brainandlife.org Favicon

biocompare.com Favicon

idse.net + 6 more

Articles

Pharmacists Show Their Worth in Pediatric Penicillin Allergy Delabeling

2 weeks ago | idse.net | Gina Shaw

Originally published by our sister publication Pharmacy Practice News By Gina Shaw A pharmacist-led penicillin allergy delabeling program for pediatric patients is safe, feasible and effective, with nearly all of the patients deemed eligible for the antibiotic class after oral challenge testing, according to new data reported at the ASHP Pharmacy Futures 2025 meeting, in Charlotte, N.C. “There is now data showing that you can safely test low-risk pediatric patients, those who did not have...
Purge of ACIP by R.F.K. Jr. Condemned by PharmDs, MDs and Others

2 weeks ago | idse.net | Gina Shaw

Originally published by our sister publication Pharmacy Practice NewsBy Gina ShawHealth and Human Services Secretary Robert F. Kennedy Jr.’s June 9 announcement that he had dismissed all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP), which guides the agency on vaccine recommendations, has been met with near-universal condemnation from top infectious disease experts and medical organizations.
Obesity Affects PKs of Newer Beta-Lactam Combinations

3 weeks ago | idse.net | Gina Shaw

By Gina ShawObesity has been associated with treatment failure in patients receiving beta-lactam antibiotics, including novel beta-lactam/beta-lactamase inhibitor combinations. Therefore, it is important that research is done to optimize therapy regimens.
Rapid Diagnostic Testing with BCID2 Panel Improves Time to Optimal Therapy

3 weeks ago | idse.net | Gina Shaw

By Gina ShawMore than half of patients with positive cultures for bloodstream infections achieved optimal therapy within 48 hours using the Biofire Blood Culture Identification 2 (BCID2; bioMérieux) panel, a rapid multiplex polymerase chain reaction–based diagnostic platform, in a single-center retrospective cohort study presented at MAD-ID 2025, in Orlando, Fla.
Pemivibart Appears to Prevent COVID-19 Infection in CLL

4 weeks ago | idse.net | Gina Shaw

By Gina ShawThe monoclonal antibody pemivibart (Pemgarda, Invivyd) is well tolerated and appears effective in preventing symptomatic COVID-19 infection among patients with chronic lymphocytic leukemia (CLL), who can be severely immunocompromised, according to a study reported at MAD-ID 2025, in Orlando, Fla. (abstract 96E).
Trump Administration Shuts Down CDC’s Top Infection Control Committee

1 month ago | idse.net | Gina Shaw

By Gina ShawThe Trump administration has eliminated the CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), a voluntary advisory committee, its members confirmed to Infectious Disease Special Edition. The explanation for its elimination was a citation of executive order 14217, “Commencing the Reduction of the Federal Bureaucracy.” Members received notification of their termination on Friday, May 2, and the committee’s web page has been archived.
Hyperautomation with Agentic Bots: Transforming Business Processes

1 month ago | ginashaw.medium.com | Gina Shaw

In the rapidly evolving digital landscape, businesses constantly seek innovative ways to enhance productivity, reduce costs, and streamline operations. Hyperautomation, as a transformative concept, integrates advanced technologies such as Robotic Process Automation (RPA), Artificial Intelligence (AI), and Machine Learning (ML) to automate end-to-end business workflows.
Overcoming Biosimilar Utilization Barriers

2 months ago | specialtypharmacycontinuum.com | Gina Shaw

The successful implementation of an infliximab biosimilar at Boston Medical Center (BMC) was one of several lessons for overcoming operational challenges and stakeholder barriers to biosimilar adoption presented during a session at the ASHP Midyear 2024 Clinical Meeting & Exhibition, in New Orleans.
Survivorship Planning for Melanoma Patients

2 months ago | pharmacypracticenews.com | Gina Shaw

By Gina Shaw3 Questions for Christina Davis, PharmD, Clinical Oncology Pharmacy Specialist, University of Colorado Anschutz Medical Campus, Aurora1. How frequently do you see patients who have been on active treatment for melanoma once they complete their initial treatment phase? For high-risk melanoma patients who have completed treatment, we usually alternate our appointments with dermatology visits.
Over-the-Counter Analgesics Improve Symptoms, Recovery Time After Concussion : Neurology Today

2 months ago | journals.lww.com | Gina Shaw

Use of over-the-counter (OTC) analgesics—including both acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs)—after a traumatic brain injury (TBI) was significantly associated with improved concussion symptoms and recovery, according to new data presented at the AAN Annual Meeting in San Diego. The prospective cohort study of National Collegiate Athletic Association (NCAA) and military cadets also found that the OTC drugs led to a quicker return to play.